AUTL 8-K 2026-01-12

Autolus Therapeutics plc (AUTL) 8-K dated 2026-01-12 — accession 0001730463-26-000012. This URL is the filing, not the AUTL hub.

Autolus Therapeutics plc (AUTL) is a biotechnology company listed on US.

Autolus Therapeutics plc filed a 8-K on 2026-01-12. Accession 0001730463-26-000012.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.

Not investment advice. The AUTL SEC hub lists recent forms. The stock page is the research view.